Literature DB >> 7086827

Apyrogenic, adjuvant-active N-acetylmuramyl-dipeptides.

P Lefrancier, M Derrien, X Jamet, J Choay, E Lederer, F Audibert, M Parant, F Parant, L Chedid.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7086827     DOI： 10.1021/jm00343a018

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  18 in total

1.  Involvement of gamma interferon in antibody enhancement by adjuvants.

Authors:  M J Odean; C M Frane; M Van derVieren; M A Tomai; A G Johnson
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

2.  Enhanced oxidative burst without interleukin 1 production by normal human polymorphonuclear leukocytes primed with muramyl dipeptides.

Authors:  C Jupin; M Parant; L Chedid; C Damais
Journal:  Inflammation       Date:  1987-06       Impact factor: 4.092

3.  Induction of biologically active antibodies by a polyvalent synthetic vaccine constructed without carrier.

Authors:  M E Jolivet; F M Audibert; H Gras-Masse; A L Tartar; D H Schlesinger; R Wirtz; L A Chedid
Journal:  Infect Immun       Date:  1987-06       Impact factor: 3.441

4.  Two adjuvant-active muramyl dipeptide analogs induce differential production of lymphocyte-activating factor and a factor causing distress in guinea pigs.

Authors:  N E Byars
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

5.  Immunotherapy of Lewis lung carcinoma with hydrosoluble peptidoglycan monomer (PGM).

Authors:  G Sava; T Giraldi; J Tomasić; I Hrsak
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

6.  Macrophages are stimulated by muramyl dipeptide to induce polymorphonuclear leukocyte accumulation in the peritoneal cavities of guinea pigs.

Authors:  S Nagao; M Nakanishi; H Kutsukake; K Yagawa; S Kusumoto; T Shiba; A Tanaka; S Kotani
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

7.  Comparison of immunomodulatory activities in mice and guinea pigs of a synthetic desmuramyl peptidolipid triglymyc.

Authors:  C D Leclerc; F M Audibert; L A Chedid; E J Deriaud; N K Masihi; E Lederer
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

8.  Effects of natural or synthetic microbial adjuvants on induction of autoimmune thyroiditis.

Authors:  Y C Kong; F Audibert; A A Giraldo; N R Rose; L Chedid
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

9.  Enhancement by murabutide of the immune response to natural and synthetic hepatitis B surface antigens.

Authors:  F M Audibert; G Przewlocki; C D Leclerc; M E Jolivet; H S Gras-Masse; A L Tartar; L A Chedid
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

10.  Modulation of myelopoiesis in vivo by synthetic adjuvant-active muramyl peptides: induction of colony-stimulating activity and stimulation of stem cell proliferation.

Authors:  A Galelli; L Chedid
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.